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Differentiation between allergic and irritant contact
dermatitis reactions is difficult, as both inflammatory
diseases are clinically, histologically, and immuno-
histologically very similar. Previous studies in mice
revealed that the chemokine IP-10 is exclusively
expressed in allergic contact dermatitis reactions. In
the present study, we investigated whether the mRNA
expression of IP-10 and the related CXCR3 activating
chemokines, Mig and IP-9 are also differentially
expressed in human allergic contact dermatitis and
irritant contact dermatitis reactions. Skin biopsies from
allergic (13 cases) and sodium lauryl sulfate-induced
irritant patch test reactions (13 cases), obtained 1–72 h
after patch testing, were studied by means of an in situ
hybridization technique. Results of chemokine mRNA
expression were correlated with clinical scoring, histo-
logy, and immunohistochemical data including the
proportion of inflammatory cells expressing CXCR3,
the receptor for IP-10, Mig, and IP-9, and ICAM-1
Differentiation between allergic contact dermatitis(ACD) and irritant contact dermatitis (ICD) isdifficult, both clinically and histologically. For thisreason, in the last two decades many studies haveattempted to define immunophenotypical criteria,
allowing differentiation between both conditions. The results of
these studies, however, have revealed similarities rather than clear-
cut differences between ACD and ICD, despite the different
pathogenic mechanisms involved in the development of these
conditions. These similarities concerned both the localization and
cellular composition of the skin infiltrates (Scheynius et al, 1984;
Willis et al, 1986), the expression of activation markers expressed
by keratinocytes, such as ICAM-1 and HLA-DR (Gawkrodger
et al, 1987; Brasch et al, 1992) and cytokine profiles (Hoefakker
et al, 1995). Taken together, these studies have been unable to
define useful histologic or immunohistologic criteria allowing
differentiation between both conditions.
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and HLA-DR expression on keratinocytes. IP-10, Mig,
and IP-9 mRNA were detected in seven of nine allergic
contact dermatitis reactions after 24–72 h, but not in
sodium lauryl sulfate-induced irritant contact derma-
titis reactions. ICAM-1 expression by keratinocytes
was only found in allergic contact dermatitis reactions
and correlated with chemokine expression. Moreover,
up to 50% of the infiltrating cells in allergic contact
dermatitis expressed CXCR3, in contrast to only 20%
in irritant contact dermatitis reactions. In conclusion,
we have demonstrated differences in chemokine
expression between allergic contact dermatitis and
irritant contact dermatitis reactions, which might
reflect different regulatory mechanisms operating in
these diseases and may be an important clue for
differentiation between allergic contact dermatitis and
irritant contact dermatitis reactions. Key words: allergic
contact dermatitis/in situ hybridization/irritant contact
dermatitis. J Invest Dermatol 113:574–578, 1999
In contrast to these studies in humans, studies in mice revealed
different cytokine expression patterns between ACD and ICD.
Using a reverse transcriptase–polymerase chain reaction technique,
Enk and Katz (1992) found expression of interleukin-1 and IP-10
mRNA in ACD but not in ICD induced by sodium lauryl sulfate
(SLS). IP-10 (Luster et al, 1985) is a member of the CXC family
of chemokines and specifically attracts activated T cells expressing
the chemokine receptor CXCR3 (Loetscher et al, 1996; Qin et al,
1998). Moreover, IP-10 has been shown to be produced abundantly
by keratinocytes upon stimulation by interferon (IFN) -γ both
in vitro (Boorsma et al, 1994, 1998) and in vivo (Kaplan et al, 1987;
Tensen et al, 1998). Two other members of the CXC family that
act through the same receptor are Mig (Farber, 1993) and IP-9
(Tensen et al, 1999a). IP-9 is a novel highly potent ligand for
CXCR3, recently isolated from IFN-γ stimulated keratinocytes in
its native biologically active form (Tensen et al, 1999a). The cDNA
encoding IP-9 is also known as b-R1 (Rani et al, 1996), H174
(Jacobs et al, 1997) or I-TAC (Cole et al, 1998).
The exclusive expression of IP-10 in ACD in mice, as observed
by Enk and Katz (1992), prompted us to study mRNA expression
of IP-10, and the closely related chemokines Mig and IP-9, in
human allergic and irritant patch test reactions using in situ
hybridization. As IP-10, Mig, and IP-9 are induced by IFN-γ the
expression of these chemokines was correlated with the expression
of ICAM-1 and HLA-DR, which are induced by IFN-γ as well
(Griffiths et al, 1989). Furthermore, the presence of CXCR3,
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Table I. Allergic test subjects, patch tests, and schedule for
taking biopsies
Case no. Allergen biopsy (h)
1 Coumarin 4 and 24
2 Nickel sulfate 4 and 24
3 Neomycin 4 and 24
4 Balsam of Peru 4 and 24
5 Kathon CG 48
6 Kathon CG 72
7 Methyldibromoglutaronitril 72
8 Imidazolidinyl urea 72
9 Epoxy resin 72
10 Sesquiterpene lactone mix 72
11 Carbamix 72
12 Epoxy resin 72
13 Thiuram 72
the receptor for IP-10, Mig, and IP-9, on infiltrating cells was
investigated.
MATERIALS AND METHODS
Subjects Thirteen volunteers with a known contact allergy, were
recruited from the contact dermatitis clinic. A further 13 healthy volunteers
without contact allergy or dermatitis, were recruited from the university
student population. The study was approved by the Hospital Ethical
Committee and the volunteers participated after giving informed consent.
Allergic patch testing Contact allergy for various allergens (Table I)
had originally been diagnosed by means of epicutaneous patch testing. For
the study, these volunteers were patch tested on the back with allergens
in generally accepted test concentrations with Van der Bend Square
chambers (Bruynzeel et al, 1995). In the first group of four volunteers, the
patches were removed and biopsies were taken after 4 and 24 h, respectively.
In the second group of nine volunteers, the patches were removed after
48 h and biopsies were taken after 72 h. The patch test reactions were
scored according to the International Contact Dermatitis Research Group
(ICDRG) guidelines: – 5 negative reaction; 1 5 weak positive reaction:
redness, induration, and possibly papules; 1 1 5 positive reaction:
erythema, induration, papules, and vesicles; 1 1 1 5 strong positive
reaction: intense erythema, induration, and coalescing vesicles.
Irritant (SLS) patch testing Thirteen healthy volunteers were patch
tested with 5% SLS in distilled water. Fifty microliters were pipetted on
filter-paper discs in Van der Bend Square chambers. The patches were
applied to the lower back at three different spots. In five volunteers,
patches were removed after 1, 3, and 6 h, respectively, and the biopsies
were taken directly after the patches were removed. In another eight
healthy volunteers, patches were removed after 24 h and a biopsy was
taken at that time-point. In five of them, two more biopsies were taken
at 48 h and at 72 h. Control biopsies were obtained from the vehicle patch
tests. The patch test reactions were scored according to the ICDRG
guidelines. The biopsies were embedded in Cryomatrix (Shandon, U.K.)
and immediately frozen in liquid nitrogen.
Immunohistochemical analysis Five micrometer frozen tissue sections
were fixed in acetone for 10 min at room temperature, and subsequently
incubated with appropriately diluted primary antibody, biotinylated goat
anti-mouse immunoglobulin antibody (DAKO, Denmark) and horseradish
peroxidase-labeled streptavidin (DAKO). Horseradish peroxidase–enzyme
activity was revealed using AEC/H2O2 as substrate solution, and the
sections were counterstained with Mayers hematoxylin (Beljaards et al,
1997). The following primary antibodies were used: CD3 and CD4 (clones
BB11 and BF5, respectively, Biosource International; Camarillo, CA), CD8
(clone BC8, Dr J. Wijdenes; Besanc¸on, France), CD54 (clone MEM111,
Monosan Uden, the Netherlands), HLA-DR (clone H2–5-10, Dutch
Red Cross Central Laboratory of Blood Transfusion; Amsterdam, the
Netherlands), neutrophil elastase (clone NP57, DAKO; Copenhagen,
Denmark), and CXCR3 (clone 49801.111, R&D Systems, Minneapolis,
MN).
Histologic examinations The amount of inflammatory cells, including
CD3, CD4, CD8, and elastase positive cells, was assessed, using a three-
point scale; –, few positive cells/as in normal skin; 1, moderate presence
of positive cells; 11, pronounced presence of positive cells. The dermal
and epidermal compartments were examined separately.
In situ hybridization Preparation of 35S labeled RNA probes: pZERO
plasmid DNA harboring IP-10 or Mig cDNA sequences (Tensen et al,
1998) or pTopo containing IP-9 cDNA (Tensen et al, 1999a) in either
orientation were linearized and 35S labeled sense (control) and anti-sense
RNA probes were obtained by in vitro transcription with T7 RNA
polymerase. After 2 h, the DNA templates were degraded with DNaseI
and the labeled riboprobes were recovered by ethanol precipitation using
20 µg t-RNA as carrier, and subsequently dissolved in formamide. In situ
hybridization procedure was performed as previously described (Tensen
et al, 1998). After fixation of the cryostat sections, the slides were overlaid
with 100 µl hybridization buffer containing 4 3 106 c.p.m. probe per
100 µl. Sections were mounted with coverslips and hybridized for 16–
18 h at 50°C in an humidified chamber. After hybridization, nonhybridized
probe was removed using high-stringency washes at 45°C. For autoradio-
graphy detection, slides were dipped in Ilford’s K5 solution, exposed for
1–5 wk, then developed using Kodak D19, and counterstained with
hematoxylin.
RESULTS
Clinical and histologic evaluation The allergic patch test
reactions were all negative (-) after 4 h and weakly positive (1)
after 24 h. After 48–72 h, two of nine were weakly positive (1)
and seven of nine were positive (11) (Table II). The irritant
patch test reactions were negative (-) after 1–6 h. After 24 h, five
of eight were weakly positive (1) and three of eight were positive
(11). After 48–72 h the irritant reactions were all weakly positive
(1) (Table II). No clinical reactions were observed for the vehicle.
The density of the infiltrates paralleled the clinical scoring. Up
to 4 h, the perivascular infiltrates in ACD resembled those in
normal skin. From 24 to 72 h, the infiltrates increased from
moderate to pronounced dense perivascular infiltrates with influx
of some CD3 positive cells in the epidermis (Table II). A relatively
constant percentage of CD3-positive cells (75%–90%) was observed,
with a CD4/CD8 ratio of approximately 2:1. The infiltrates in
ICD reactions were most pronounced at 24 h and contained a
relatively high percentage of neutrophils (5%–25%) compared with
less than 5% in ACD reactions. Superficial necrosis was also seen
in a few cases of ICD reactions.
The percentage of inflammatory cells positive for the receptor
CXCR3 in the ACD reactions varied between 25% and 50%,
whereas in the ICD reactions 10%–30% of the cells were positive
(Table II). The CXCR3 positive cells were observed mainly in
the dermal infiltrates.
Expression of IP-10, Mig, and IP-9 mRNA The ACD
reactions showed a time-dependent expression of IP-10, Mig, and
IP-9 mRNA which concurred with the clinical manifestations. At
4 h no detectable signals were observed. At 24 h, few IP-10- and
Mig-positive cells were seen at sites of close contact between
inflammatory cells and the keratinocytes (two of four cases), whereas
IP-9 mRNA was not detectable. After 48–72 h, IP-10, Mig, and
IP-9 were positive in most of the biopsies. In seven of nine biopsies,
IP-10 was found to be strongly expressed in the epidermis as well
as the upper dermis (Fig 1a, b; Table II). In the other two biopsies,
IP-10 expression was minimal or absent. Consistently, in one of
these cases, the clinical reaction was also weakly positive and the
infiltrate was only moderate. The expression of Mig mRNA was
similar to IP-10 mRNA expression, although, Mig was found more
abundantly in the dermis (Fig 1c, d; Table II). IP-9 mRNA was
restricted to the epidermis and roughly paralleled IP-10 mRNA
expression, but was generally less pronounced (Fig 1e, f; Table II).
In general, expression of chemokine mRNA correlated with the
clinical reaction and the density of the infiltrates. In particular,
where inflammatory cells were in close apposition to the epidermis,
the keratinocytes as well as infiltrating cells abundantly expressed
mRNA encoding chemokines.
Hybridization of the irritant patch test reactions with IP-10
(Fig 2a, b), Mig, and IP-9 did not show any detectable signal up
to 72 h. (Table II). Similarly, there was no detectable expression
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Table II. Clinical, immunohistologic and in situ hybridization data from the allergic and irritant patch test reactions
Allergic patch test reactions Irritant patch test reactions
4 h 24 h 48–72 h 1–6 h 24 h 48–72 h
n 5 number of biopsies n 5 4 n 5 4 n 5 9 n 5 15 n 5 8 n 5 10
Clinical scorea – 1 1/11 – 1/11 1
Inflammatory cellsb
Epidermis – 1c 1/11c – 1/11d 1d
Dermis – 1c 1/11c – 1/11d 1/11d
Keratinocyte expresse
ICAM-1 – 6 1/11 6 6 6
HLA-DR – – 6/1 – – –
IP-10 expressionf
Epidermis – –/6 1/11 – – –
Dermis – – 1/11 – – –
Mig expressionf
Epidermis – –/6 1/11 – – –
Dermis – – 1/11 – – –
IP-9 expressionf
Epidermis – – 6/1 – – –
Dermis – – 6 – – –
CXCR3g 25–50% 25–50% 10–30% 10–30%
a–, negative reaction; 1, weakly positive reaction; 11, positive reaction.
b–, few cells/as in normal skin; 1, moderate infiltrate; 11, pronounced infiltrate.
cMainly lymphocytes.
dMixed infiltrates of mononuclear cells and neutrophils.
e–, no staining; 6, faint staining of basal layer keratinocytes; 1, focal areas of strong staining of basal layer keratinocytes; 11, extensive areas of strong staining of basal
and supra basal layer keratinocytes.
f–, no expression; 6, minimal expression; 1, focal strong expression; 11, diffuse strong expression.
gPercentage of inflammatory cells expressing CXCR3.
of IP-10, Mig, or IP-9 mRNA in normal or control skin (data
not shown).
ICAM-1 and HLA-DR expression by keratinocytes In the
ACD reactions, the ICAM-1 expression by keratinocytes was only
found at sites where inflammatory cells were in close contact
with the epidermis, and correlated well with chemokine mRNA
expression. At 4 h, the keratinocytes were consistently negative as
in normal skin. From 24 to 72 h, the ICAM-1 expression increased
from focal expression on basal layer keratinocytes to areas of
extensive expression on basal and suprabasal layer keratinocytes
(Table II). On the other hand, HLA-DR expression was not
observed until 72 h, by then, only sparse foci of positive keratino-
cytes were observed (Table II). HLA-DR expression on keratino-
cytes did not correspond with the chemokine mRNA expression.
In contrast with the ACD reactions, the ICD reactions were
negative or showed weak focal expression for ICAM-1 from 1 h
up to 72 h. In addition, HLA-DR expression was not detected in
any of the ICD biopsies (Table II).
Besides keratinocytes, ICAM-1 and HLA-DR were also
expressed by inflammatory cells as well as by endothelial cells in
both the ACD and the ICD reactions.
DISCUSSION
The aim of the present study was to investigate whether there are
differences between ACD and ICD reactions in the expression of the
CXC chemokines IP-10, Mig, and IP-9. These CXC chemokines
specifically interact with the receptor CXCR3 which is nearly
exclusively expressed on activated T cells. Radioactive mRNA in
situ hybridization was used to detect chemokine expression at
different time-points of well-defined experimentally induced ACD
reactions and SLS-induced ICD reactions.
Our results clearly demonstrate differences in the expression of
IP-10, Mig, and IP-9 mRNA between ACD and ICD reactions.
In ACD reactions, a time-dependent increase of chemokine mRNA
expression was observed which concurred with the influx of T
cells. At 24 h the amount of chemokine expression is still very low
and is preceded by small amounts of T cells at the dermal–epidermal
junction. This suggests that the initial recruitment of these cells is
controlled by other chemotactic factors. At later time-points (48
and 72 h) the increased expression of IP-10, Mig, and IP-9 indicates
involvement of these chemokines in the amplification of the
inflammatory process. IP-10 was most abundant, and predominantly
expressed by epidermal cells. Mig was expressed in both epidermis
and dermis, whereas IP-9 was mainly expressed by epidermal cells,
although to a much lower extent compared with IP-10. In contrast,
the ICD reactions were consistently negative. In addition to
chemokine expression, up to 50% of the infiltrating cells in the
ACD reactions expressed CXCR3, the cognate receptor for IP-
10, Mig, and IP-9, whereas at most 30% of the cells in the ICD
reaction expressed CXCR3. Recent double staining experiments
on skin biopsies from various inflammatory dermatoses, including
some of the ACD and ICD reactions presented herein, indicate
that both in ACD and ICD reactions CXCR3 is expressed by
CD4 1 as well as CD8 1 T cells (Flier et al, unpublished
observations).
The differential expression of IP-10 in human ACD and ICD
reactions is consistent with the results of previous studies in mice
(Enk and Katz, 1992) and suggests that this CXCR3 activating
chemokine plays an important part in the generation of the
inflammatory infiltrates in ACD in humans, but not in the SLS-
induced ICD reactions. Furthermore, we show here that the related
CXC chemokines Mig and IP-9 are also exclusively expressed in
ACD reactions. Expression of IP-10 and Mig has also been found
in other skin diseases like cutaneous T cell lymphomas (Tensen
et al, 1998), psoriasis (Goebeler et al, 1998), and lichen planus
(Spandau et al, 1998).
In addition to the differences in chemokine mRNA and chemo-
kine receptor expression, we observed other, less pronounced
differences between the ACD and ICD reactions. First, the dermal
infiltrates in ACD were more pronounced than in ICD, even if
the clinical score was identical. Similar observations have been
made by other groups (Scheynius et al, 1984; Gawkrodger et al,
1987). Second, whereas neutrophils were rare in ACD, considerable
numbers of neutrophils were found in SLS-induced ICD reactions.
They were most pronounced in cases with focal necrosis and
peaked at 24 h. Consistently, we found interleukin-8 mRNA in
SLS-induced ICD reactions using in situ hybridization (Flier et al
unpublished observations). Interleukin-8 attracts neutrophils by
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Figure 1. Characteristic patterns of IP-10, Mig,
and IP-9 mRNA expression in an allergic contact
dermatitis reaction. In situ hybridization with 35S-
UTP-labeled anti-sense RNA and sense RNA probes
followed by emulsion autoradiography was performed
on cryostat sections of an ACD reaction as described
in Materials and Methods. Silver grains representing sites
of IP-10 mRNA transcripts are found in both the
epidermis and dermis: (A) bright-field and (B) dark-
field illumination of the same section. Mig mRNA was
detected more pronounced in the dermis compared
with the epidermis; (C) bright-field and (D) dark-field
illumination. IP-9 mRNA was focally expressed mainly
by epidermal cells: (E) bright-field and (F) dark-field
illumination. Specificity of the hybridization procedure
was demonstrated using an IP-10 sense RNA probe on
a serial section of the same biopsy showing absence
of silver grains: (G) bright-field and (H) dark-field
illumination. Scale bar: (a–h) 140 mm.
Figure 2. Absence of IP-10 mRNA expression in
a representative section of a SLS-induced ICD
reaction. In situ hybridization with 35S-UTP-labeled
IP-10 anti-sense RNA followed by emulsion autoradio-
graphy was performed on cryostat sections as described
in Materials and Methods. Absence of silver grains
reflects lack of expression of IP-10 mRNA in the SLS-
induced ICD reaction; (A) bright-field and (B) dark-
field illumination of the same section. Scale bar: (a,b)
140 mm.
binding to either the CXCR1 or CXCR2 expressed on neutrophils
(He´bert and Baker, 1993; Chuntharapai et al, 1994).
Furthermore, immunohistochemical evaluation of ICAM-1 and
HLA-DR expression by keratinocytes revealed expression of
ICAM-1 after 24 h and HLA-DR after 72 h in ACD reactions
only. Previous studies on ICAM-1 and HLA-DR expression have
revealed some conflicting data, probably due to differences in
allergens and irritants used and in the time of biopsy. ICAM-1 and
HLA-DR expression have been reported to be expressed in ACD
(Lange Vejlsgaard et al, 1989; Garioch et al, 1991) and also in ICD
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(Gawkrodger et al, 1987; Willis et al, 1991; Brasch et al, 1992). For
HLA-DR expression, 72 h might have been too early according
to in vivo observations done by Scheynius and Fischer (1986).
The results of our study, showing explicit differences in expression
of IP-10, Mig, and IP-9 as well as more gradual differences in a
number of histologic and immunohistochemical parameters, seem
to reflect the different pathogenic mechanisms involved in the
development of ACD and ICD reactions.
As IFN-γ induces not only the expression of ICAM-1 and
HLA-DR but also the expression of CXCR3 activating CXC
chemokines, it is reasonable to assume that correlation between
the expression of IP-10, Mig, IP-9, and ICAM-1 can be explained
by the local presence of IFN-γ in these ACD reactions. Recently,
in allergic individuals, activated T cells producing IFN-γ were
identified (Cavani et al, 1998). Our data suggest that IFN-γ
produced by these activated T cells might play a part in these ACD
reactions by inducing the expression of IP-10, Mig, and IP-9.
Epidermal keratinocytes are well known producers of these chemo-
kines (Boorsma et al, 1998; Tensen et al, 1999a), although the
identity of the producing cells in the dermis is difficult to establish.
In vitro studies showed that both monocytes/macrophages,
fibroblasts, and endothelial cells express the mRNAs encoding
these chemokines upon stimulation with IFN-γ (Tensen et al,
1999b). As close examination of the sections revealed that endo-
thelial cells were negative, both monocytes/macrophages and
fibroblasts are possible sources of dermal chemokine mRNA in
these ACD reactions. It appears that expression of these CXC
chemokines by dermal and epidermal cells contributes to an
environment in which activated T cells, bearing the CXCR3
receptor are able to migrate to the site of allergen reaction, thereby
enhancing and maintaining the inflammatory infiltrate. In addition,
the interaction between T cells and keratinocytes contributing
to the production of chemokines and upregulation of adhesion
molecules, appears to be crucial in the ACD reaction. Expression
of IP-10, Mig, and IP-9 was not observed in SLS-induced ICD
reactions, at least not in the first 72 h. Moreover, the interaction
of the dermal infiltrates with the epidermis in these reactions was
less pronounced. Yet, it remains unclear, which chemokines regulate
the migration of inflammatory cells in an irritant reaction and
thereby contribute to the development of the inflammatory
response. With the mild damage to keratinocytes, irritants induce
a cascade of common inflammatory mechanisms in which inter-
leukin-1 and tumor necrosis factor-α are involved (Berardesca,
1997). Further research is required to elucidate the role of chemo-
kines in ICD reactions not only induced by SLS but also by other
irritants. If IP-10, Mig, and IP-9 are neither expressed in ICD
reactions induced by other irritants, expression of these chemokines
may be an important clue for differentiation between allergic and
irritant contact reactions.
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